Committee on Safety of Medicines debates Vioxx CV risks based on MHRA 2001 report

This material is from a 2005 investigation by Brian Deer for The Sunday Times of London into the painkiller Vioxx | Go to Vioxx index

The document below is a restricted report, titled "The cardiovascular safety of rofecoxib (and other selective COX-2 inhibitors)", by the UK Medicines and Healthcare products Regulatory Agency submitted to a meeting of the British government's Committee on Safety of Medicines held on December 12 2001

Notes: Redactions to this document are by the UK Medicines and Healthcare products Regulatory Agency on supply to Brian Deer under freedom of information law. Annexes may be available by emailing Brian Deer, but supply isn't guaranteed. Please support investigative journalism by linking to this page and/or crediting this website: briandeer.com